Skip to main content
All lobbying filings

MEDSECUREAN.COM

Lobbying for LUPIN PHARMACEUTICALS · Lupin Pharmaceuticals is a generic manufacturing company

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Feb 14, 2026
Income
$42,000.00
What the client paid this registrant for the period.
Client based in
Florida

Official filing document

 Government bodies contacted 6
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
  • SENATE
  • State, Dept of (DOS)
  • U.S. Trade Representative (USTR)
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Generic Industry Sustainability and tariifs broadly.

Trade (domestic/foreign)

Tarrifs - generic medicine

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem